Geneva, March 23 -- International Clinical Trials Registry received information related to the study (NCT07459712) titled 'Pharmacokinetics and Pharmacodynamics of THS With LEVIA Compared to THS With TEREA and to Cigarettes' on March 5.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Crossover Assignment. Primary purpose: Basic Science. Masking: None (Open Label).
Primary Sponsor: Philip Morris Products S.A.
Condition:
Nicotine
Intervention:
Other: THS with LEVIA (ad libitum)
Other: THS with TEREA (ad libitum)
Other: THS with LEVIA
Other: THS with TEREA
Recruitment Status: Not recruiting
Phase: N/A
Date of First Enrollment: February 1, 2026
Target Sample Size: 24
Countries of Recruitme...